Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.400
-0.140 (-5.51%)
At close: Mar 20, 2026, 4:00 PM EDT
2.420
+0.020 (0.83%)
After-hours: Mar 20, 2026, 6:30 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $107.53 million as of March 20, 2026. Its market cap has decreased by -15.47% in one year.
Market Cap
107.53M
Enterprise Value
94.62M
1-Year Change
-15.47%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $107.53M, a decrease of -24.11%. That is a compound annual growth rate of -8.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 106.49M | -35.07% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 111.62M |
| Rani Therapeutics Holdings | 110.22M |
| Innate Pharma | 109.65M |
| Inovio Pharmaceuticals | 109.17M |
| Aldeyra Therapeutics | 108.93M |
| Oncolytics Biotech | 102.23M |
| Turn Therapeutics | 101.29M |
| Dogwood Therapeutics | 100.20M |